Brainpaths safe alternative to Minimally Invasive Brain Stimulation
Brainpaths brain stimulation devices are registered with the FDA as a medical device; medical specialty: neurology. FDA registered Brainpaths as a non-powered surgical instrument, Product Code: HAO Class: 1, Regulation #: 882.4535. Brainpaths LLC is a FDA Registered Establishment, Number: 3010937782.
Brainpaths uses braille-sized textures to stimulate the brain; no electrodes are necessary because Brainpaths textures indent into 3000 mechanoreceptors under the skin of each fingertip to provide a superhighway to the sensory cortex of the brain. Just like Braille, Brainpaths uses fingertips to stimulate the brain and since all ten fingertips can be used simultaneously, Brainpaths brain stimulation is ten times as powerful as Braille.
Since Brainpaths devices are non-invasive with no side effects, Brainpaths may be an alternative to using DBS and TMS brain stimulation. Mayo Clinic recently has determined Deep Brain Stimulation (DBS) and Trans Magnetic Stimulation (TMS) have side effects, as referenced below.
Side Effects: Deep Brain Stimulations (DBS) Mayo Clinic E-Newsletter May 14, 2014 (Link): http://www.mayoclinic.org/tests-procedures/deep-brain-stimulation/basics/risks/prc-20019122
Although deep brain stimulation is generally safe, any type of surgery has the risk of complications. Deep brain stimulation involves boring small holes in the skull to implant the electrodes, and surgery to implant the device that contains the batteries under the skin in the chest. Side effects associated with deep brain stimulation may include: seizure, infection, headache, insomnia, memory problems, temporary pain and swelling at the implantation site; numbness or tingling sensations, muscle tightness of the face or arm, speech problems, balance problems, lightheadedness, unwanted mood changes, such as mania and depression.
Transcranial magnetic stimulation (TMS) Mayo Clinic February 4, 2015 http://www.mayoclinic.org/testsprocedures/transcranial-magnetic-stimulation/basics/risks/prc-20020555
Transcranial magnetic stimulation (TMS) is the least invasive of the brain-stimulation procedures used for depression. Unlike vagus nerve stimulation or deep brain stimulation, TMS doesn’t require surgery or implantation of electrodes. TMS often causes minor short-term side effects. These side effects are generally mild and typically improve after the first week or two of treatment. They can include: headache, scalp discomfort at the site of stimulation, tingling, spasms or twitching of facial muscles, lightheadedness, discomfort from noise during treatment.
Brainpaths devices stimulate the brain as fingertips trace injected plastic textures, indenting into 3000 mechanoreceptors in each fingertip. Brainpaths is non invasive and provides brain stimulation without side effects. Alzheimer’s Foundation Store is now selling Brainpaths; also purchase Brainpaths on Amazon, EBay and Brainpaths.com.
